rs200437377

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_182914.3(SYNE2):​c.3506G>A​(p.Arg1169His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000949 in 1,613,294 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1169C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00099 ( 1 hom. )

Consequence

SYNE2
NM_182914.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: 0.167

Publications

0 publications found
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SYNE2 Gene-Disease associations (from GenCC):
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Emery-Dreifuss muscular dystrophy 5, autosomal dominant
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • left ventricular noncompaction
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.036743402).
BP6
Variant 14-64000587-G-A is Benign according to our data. Variant chr14-64000587-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 282514.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000532 (81/152212) while in subpopulation NFE AF = 0.000926 (63/68012). AF 95% confidence interval is 0.000742. There are 0 homozygotes in GnomAd4. There are 35 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 81 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE2NM_182914.3 linkc.3506G>A p.Arg1169His missense_variant Exon 28 of 116 ENST00000555002.6 NP_878918.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE2ENST00000555002.6 linkc.3506G>A p.Arg1169His missense_variant Exon 28 of 116 1 NM_182914.3 ENSP00000450831.2 Q8WXH0-2A0A0C4DGK3

Frequencies

GnomAD3 genomes
AF:
0.000533
AC:
81
AN:
152094
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000926
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000494
AC:
123
AN:
249150
AF XY:
0.000525
show subpopulations
Gnomad AFR exome
AF:
0.000452
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000920
Gnomad OTH exome
AF:
0.000331
GnomAD4 exome
AF:
0.000992
AC:
1450
AN:
1461082
Hom.:
1
Cov.:
31
AF XY:
0.000985
AC XY:
716
AN XY:
726856
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33450
American (AMR)
AF:
0.000246
AC:
11
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26106
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39572
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86190
European-Finnish (FIN)
AF:
0.000169
AC:
9
AN:
53388
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5760
European-Non Finnish (NFE)
AF:
0.00122
AC:
1360
AN:
1111586
Other (OTH)
AF:
0.000812
AC:
49
AN:
60338
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
65
130
195
260
325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000532
AC:
81
AN:
152212
Hom.:
0
Cov.:
32
AF XY:
0.000470
AC XY:
35
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41532
American (AMR)
AF:
0.000262
AC:
4
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10590
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000926
AC:
63
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000931
Hom.:
1
Bravo
AF:
0.000521
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000556
AC:
2
ESP6500EA
AF:
0.00111
AC:
9
ExAC
AF:
0.000422
AC:
51
EpiCase
AF:
0.00115
EpiControl
AF:
0.00130

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:3
Jun 19, 2023
Revvity Omics, Revvity
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:2
Jan 16, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3506G>A (p.R1169H) alteration is located in exon 28 (coding exon 27) of the SYNE2 gene. This alteration results from a G to A substitution at nucleotide position 3506, causing the arginine (R) at amino acid position 1169 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Oct 25, 2016
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Aug 07, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SYNE2-related disorder Benign:1
Jan 10, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
6.7
DANN
Benign
0.26
DEOGEN2
Benign
0.0088
.;T;T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.20
T;T;T;T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.037
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N;.;N;.
PhyloP100
0.17
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.10
N;.;N;N
REVEL
Benign
0.027
Sift
Benign
0.51
T;.;T;T
Sift4G
Benign
0.59
T;T;T;T
Polyphen
0.0
B;.;B;.
Vest4
0.17
MVP
0.36
MPC
0.055
ClinPred
0.0015
T
GERP RS
-1.6
Varity_R
0.021
gMVP
0.062
Mutation Taster
=292/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200437377; hg19: chr14-64467305; COSMIC: COSV59941496; COSMIC: COSV59941496; API